Internal Medicine, Cardiovascular Disease · West Palm Beach, FL
NPI
1255323093
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
3472 Forest Hill Blvd, Suite 3b
West Palm Beach, FL, 33406
Phone (561) 619-3051
Groups this clinician bills Medicare through
Medicare paid, 2024
$515K
9,958 services
Medicare patients, 2024
361
Average age 76
Drug cost, 2024
$11.8M
25,602 prescriptions
Company payments, 2025
$2,498
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mauricio Melhado was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 4,680 times for 52 patients. In total Mauricio Melhado billed 9,958 services in 56 codes, and Medicare paid $515K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-19.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 4,680 | 52 | $0.10 | $481 |
| 99214 Office E&M - Established | Office | 636 | 283 | $104.50 | $66K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 460 | 115 | $5.91 | $2,719 |
| 93298 External Electrocardiographic Monitoring | Office | 432 | 80 | $80.86 | $35K |
| 93000 Electrocardiogram | Office | 379 | 286 | $12.00 | $4,547 |
| 99213 Office E&M - Established | Office | 357 | 239 | $76.42 | $27K |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 288 | 143 | $104.43 | $30K |
| 93306 Echocardiography (TTE/TEE) | Office | 235 | 231 | $161.59 | $38K |
| 93356 Echocardiography (TTE/TEE) | Office | 228 | 212 | $31.61 | $7,207 |
| 78452 Myocardial Perfusion Scan | Office | 145 | 144 | $364.07 | $53K |
| 93015 Electrocardiogram | Office | 145 | 144 | $61.56 | $8,926 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 145 | 144 | $0.52 | $75.06 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 130 | 129 | $160.53 | $21K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 125 | 90 | $32.83 | $4,104 |
| 93296 External Electrocardiographic Monitoring | Office | 92 | 37 | $16.85 | $1,551 |
By year: 2022 $859K for 10,059 services; 2023 $645K for 15,958 services; 2024 $515K for 9,958 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mauricio Melhado prescribed most often to Medicare patients was Rosuvastatin Calcium, with 2,634 prescriptions and refills. In total Mauricio Melhado wrote 25,602 Medicare prescriptions that cost $11.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 2,634 | 5,733 | 749 | $23K |
| Eliquis Apixaban | 1,860 | 2,551 | 380 | $1.5M |
| Jardiance Empagliflozin | 1,732 | 2,293 | 356 | $1.3M |
| Xarelto Rivaroxaban | 1,473 | 2,121 | 305 | $1.2M |
| Metoprolol Succinate Generic | 1,444 | 2,860 | 412 | $11K |
| Ezetimibe Generic | 1,250 | 2,646 | 382 | $18K |
| Farxiga Dapagliflozin Propanediol | 1,052 | 1,376 | 229 | $771K |
| Entresto Sacubitril/Valsartan | 1,018 | 1,337 | 208 | $882K |
| Spironolactone Generic | 993 | 1,894 | 246 | $4,304 |
| Carvedilol Generic | 962 | 1,982 | 229 | $5,827 |
| Ranolazine Er Ranolazine | 948 | 1,633 | 223 | $63K |
| Clopidogrel Clopidogrel Bisulfate | 866 | 1,754 | 231 | $5,984 |
| Bisoprolol Fumarate Generic | 865 | 1,645 | 214 | $14K |
| Atorvastatin Calcium Generic | 833 | 1,832 | 277 | $5,441 |
| Amlodipine Besylate Generic | 787 | 1,647 | 240 | $2,749 |
Brand drugs: - claims; generic drugs: 16,896 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mauricio Melhado $2,498 ($2,498 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $344.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 15 | $344 |
| E.R. Squibb & Sons, L.L.C. BMY | 20 | $309 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $253 |
| Abbott Laboratories ABT | 7 | $196 |
| BridgeBio Pharma, Inc. BBIO | 12 | $187 |
| Novo Nordisk Inc NVO | 7 | $173 |
| Amgen Inc. AMGN | 10 | $166 |
| Pfizer Inc. PFE | 9 | $164 |
| Actelion Pharmaceuticals US, Inc. JNJ | 5 | $153 |
| Merck Sharp & Dohme LLC MRK | 8 | $147 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.